Danaher Dental Spinoff Envista Closes First Day of Trading Up
Envista, which includes the Ormco, KaVo Kerr, and Nobel Biocare dental brands, closed its first day of public trading with its share price up 27% over the initial price offered.
Envista, which includes the Ormco, KaVo Kerr, and Nobel Biocare dental brands, closed its first day of public trading with its share price up 27% over the initial price offered.
The FDA has released new guidance stating clear aligners are not authorized for direct-to-consumer sales without a prescription and dental supervision, citing increased risk of complications without professional oversight.